According to the research report, the global mHealthApps market size is expected to touch USD 340.5Billion by 2030, from USD 40.2 Billion in 2021, growing with a significant CAGR of 26.79% from 2022 to 2030.
The mHealth Apps market report offers a
comprehensive study of the current state expected at the major drivers, market
strategies, and key vendors’ growth. The report presents energetic visions to
conclude and study the market size, market hopes, and competitive surroundings.
The research also focuses on the important achievements of the market, research
& development, and regional growth of the leading competitors operating in
the market. The current trends of the global mHealth Apps market in conjunction
with the geographical landscape of this vertical have also been included in
this report.
The report offers intricate dynamics about
different aspects of the global mHealth Apps market, which aids companies operating
in the market in making strategic development decisions. The study also
elaborates on significant changes that are highly anticipated to configure
growth of the global mHealth Apps market during the forecast period. It also
includes a key indicator assessment that highlights growth prospects of this
market and estimates statistics related to growth of the market in terms of
value (US$ Mn) and volume (tons).
Sample Link https://www.precedenceresearch.com/mhealth-apps-market
Report Highlights | Details |
Market Size | USD 340.5 Billion by 2030 |
Growth Rate | CAGR of 26.79% from 2022 to 2030 |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Base Year | 2021 |
Forecast Period | 2022 to 2030 |
Segments Covered | Type, Region |
This study covers a detailed segmentation
of the global mHealth Apps market, along with key information and a competition
outlook. The report mentions company profiles of players that are currently
dominating the global mHealth Apps market, wherein various developments,
expansions, and winning strategies practiced and implemented by leading players
have been presented in detail.
Key Players
- Abbott Laboratories
- Johnson and Johnson
- AstraZeneca PLC
- Hoffmann-La Roche Ltd.
- Novartis AG
- Bristol-Myers Squibb Company
- GlaxoSmithKline plc
- Merck and Co., Inc.
- Pfizer, Inc.
- iHealth Labs Inc.
- Vivify Health
- Medtronic MiniMed, Inc.
Market Segmentation
- Nutrition & Diet
- Women's Health
- Medication Adherence
- Fitness
- Lifestyle Management
- Healthcare Providers/Payers
- Disease Management
- Others
By Regional Outlook
- North America
- The U.S.
- Canada
- Europe
- The U.K.
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of the World
Research Methodology
The research methodology adopted by
analysts for compiling the global mHealth Apps market report is based on
detailed primary as well as secondary research. With the help of in-depth
insights of the market-affiliated information that is obtained and legitimated
by market-admissible resources, analysts have offered riveting observations and
authentic forecasts for the global market.
During the primary research phase, analysts
interviewed market stakeholders, investors, brand managers, vice presidents,
and sales and marketing managers. Based on data obtained through interviews of
genuine resources, analysts have emphasized the changing scenario of the global
market.
For secondary research, analysts
scrutinized numerous annual report publications, white papers, market
association publications, and company websites to obtain the necessary understanding
of the global mHealth Apps market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global mHealth Apps Market, By Type
7.1. mHealth Apps Market, by Type, 2020-2030
7.1.1. Nutrition & Diet
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Women's Health
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. Medication Adherence
7.1.3.1. Market Revenue and Forecast (2017-2030)
7.1.4. Fitness
7.1.4.1. Market Revenue and Forecast (2017-2030)
7.1.5. Lifestyle Management
7.1.5.1. Market Revenue and Forecast (2017-2030)
7.1.6. Healthcare Providers/Payers
7.1.6.1. Market Revenue and Forecast (2017-2030)
7.1.7. Disease Management
7.1.7.1. Market Revenue and Forecast (2017-2030)
7.1.8. Others
7.1.8.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global mHealth Apps Market, Regional Estimates and Trend Forecast
8.1. North America
8.1.1. Market Revenue and Forecast, by Type (2017-2030)
8.1.2. U.S.
8.1.3. Rest of North America
8.1.3.1. Market Revenue and Forecast, by Type (2017-2030)
8.2. Europe
8.2.1. Market Revenue and Forecast, by Type (2017-2030)
8.2.2. UK
8.2.2.1. Market Revenue and Forecast, by Type (2017-2030)
8.2.3. France
8.2.3.1. Market Revenue and Forecast, by Type (2017-2030)
8.2.4. Rest of Europe
8.2.4.1. Market Revenue and Forecast, by Type (2017-2030)
8.3. APAC
8.3.1. Market Revenue and Forecast, by Type (2017-2030)
8.3.2. India
8.3.2.1. Market Revenue and Forecast, by Type (2017-2030)
8.3.3. China
8.3.3.1. Market Revenue and Forecast, by Type (2017-2030)
8.3.4. Japan
8.3.4.1. Market Revenue and Forecast, by Type (2017-2030)
8.3.5. Rest of APAC
8.3.5.1. Market Revenue and Forecast, by Type (2017-2030)
8.4. MEA
8.4.1. Market Revenue and Forecast, by Type (2017-2030)
8.4.2. GCC
8.4.2.1. Market Revenue and Forecast, by Type (2017-2030)
8.4.3. North Africa
8.4.3.1. Market Revenue and Forecast, by Type (2017-2030)
8.4.4. South Africa
8.4.4.1. Market Revenue and Forecast, by Type (2017-2030)
8.4.5. Rest of MEA
8.4.5.1. Market Revenue and Forecast, by Type (2017-2030)
8.5. Latin America
8.5.1. Market Revenue and Forecast, by Type (2017-2030)
8.5.2. Brazil
8.5.2.1. Market Revenue and Forecast, by Type (2017-2030)
8.5.3. Rest of LATAM
8.5.3.1. Market Revenue and Forecast, by Type (2017-2030)
Chapter 9. Company Profiles
9.1. Abbott Laboratories
9.1.1. Company Overview
9.1.2. Product Offerings
9.1.3. Financial Performance
9.1.4. Recent Initiatives
9.2. Johnson and Johnson
9.2.1. Company Overview
9.2.2. Product Offerings
9.2.3. Financial Performance
9.2.4. Recent Initiatives
9.3. AstraZeneca PLC
9.3.1. Company Overview
9.3.2. Product Offerings
9.3.3. Financial Performance
9.3.4. Recent Initiatives
9.4. Hoffmann-La Roche Ltd.
9.4.1. Company Overview
9.4.2. Product Offerings
9.4.3. Financial Performance
9.4.4. Recent Initiatives
9.5. Novartis AG
9.5.1. Company Overview
9.5.2. Product Offerings
9.5.3. Financial Performance
9.5.4. Recent Initiatives
9.6. Bristol-Myers Squibb Company
9.6.1. Company Overview
9.6.2. Product Offerings
9.6.3. Financial Performance
9.6.4. Recent Initiatives
9.7. GlaxoSmithKline plc
9.7.1. Company Overview
9.7.2. Product Offerings
9.7.3. Financial Performance
9.7.4. Recent Initiatives
9.8. Merck and Co., Inc.
9.8.1. Company Overview
9.8.2. Product Offerings
9.8.3. Financial Performance
9.8.4. Recent Initiatives
9.9. Pfizer, Inc.
9.9.1. Company Overview
9.9.2. Product Offerings
9.9.3. Financial Performance
9.9.4. Recent Initiatives
9.10. iHealth Labs Inc.
9.10.1. Company Overview
9.10.2. Product Offerings
9.10.3. Financial Performance
9.10.4. Recent Initiatives
9.11. Vivify Health
9.11.1. Company Overview
9.11.2. Product Offerings
9.11.3. Financial Performance
9.11.4. Recent Initiatives
9.12. Medtronic MiniMed, Inc.
9.12.1. Company Overview
9.12.2. Product Offerings
9.12.3. Financial Performance
9.12.4. Recent Initiatives
Chapter 10. Research Methodology
10.1. Primary Research
10.2. Secondary Research
10.3. Assumptions
Chapter 11. Appendix
11.1. About Us
11.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1
774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
0 Comments